July 6, 2020
Stephanie Cherestal, Ph.D. guides parents on ways to speak to your kids about racism in America. She also gives tips on how to encourage children to get involved; offering helpful ways parents can inspire kids to make a difference.
July 3, 2020
Dr. Jeffrey Laurence answers questions about emerging treatments for abnormal blood clotting in severe COVID-19 cases.
July 2, 2020
We’re excited to offer this free fitness opportunity with the Hudson River Park. Our hope is that our parks and special partnerships help play a role in planning safe summer activities in the city.
June 22, 2020
Constance Zhou, MD-PhD Candidate and Co-Executive Director of Wellness Clinic discusses the recent impacts from the pandemic on the LGBTQ community and the changes to this year's Pride month.
June 16, 2020
We’re proud to be partners with the Hunters Point Park Conservancy to bring the Long Island City community a series of free fitness classes that will be available online this summer.
June 11, 2020
Weill Cornell Medicine, Bend + Bloom Yoga, and Prospect Park Alliance announce the 12th annual Prospect Park Yoga series, beginning Thursday, June 11, 2020 through September 3.
June 10, 2020
Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, addresses the issues of racial inequality and police brutality in our country and how we will continue to promote a culture of diversity and inclusion at our institution.
June 5, 2020
In randomized clinical trials, commercial sponsorship influences how studies are designed and the results reported in ways that often benefit the study’s sponsor, Weill Cornell Medicine and NewYork-Presbyterian investigators report.
June 3, 2020
If you believe that you may have had COVID-19 and did not get tested while you were ill, you might be a perfect candidate for an antibody test. Many medical institutions and walk-in clinics around the country are now offering this vital test to help reduce some uncertainty.
May 28, 2020
A triple combination of an investigational drug that enables immune cells to infiltrate tumors, an immunotherapy drug and chemotherapy showed promising responses in patients with the most common type of metastatic pancreatic cancer, according to data from an international phase 2a clinical trial led by Weill Cornell Medicine and Beth Israel Deaconness Medical Center investigators.
